BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10408832)

  • 41. Activation of fibroblast-derived matrix metalloproteinase-2 by colon-cancer cells in non-contact Co-cultures.
    Ko K; Yazumi S; Yoshikawa K; Konda Y; Nakajima M; Chiba T; Takahashi R
    Int J Cancer; 2000 Jul; 87(2):165-71. PubMed ID: 10861469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
    Jo M; Thomas LE; Wheeler SE; Curry TE
    Biol Reprod; 2004 Apr; 70(4):1024-32. PubMed ID: 14668206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of an active site of EMMPRIN for the augmentation of matrix metalloproteinase-1 and -3 expression in a co-culture of human uterine cervical carcinoma cells and fibroblasts.
    Sato T; Ota T; Watanabe M; Imada K; Nomizu M; Ito A
    Gynecol Oncol; 2009 Aug; 114(2):337-42. PubMed ID: 19427027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells.
    Fishman DA; Liu Y; Ellerbroek SM; Stack MS
    Cancer Res; 2001 Apr; 61(7):3194-9. PubMed ID: 11306508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activated matrix metalloproteinase-2--a potential marker of prognosis for epithelial ovarian cancer.
    Wu X; Li H; Kang L; Li L; Wang W; Shan B
    Gynecol Oncol; 2002 Jan; 84(1):126-34. PubMed ID: 11748988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of MMP-9 release from human dermal fibroblasts by thrombin: involvement of JAK/STAT3 signaling pathway in MMP-9 release.
    Wang L; Luo J; He S
    BMC Cell Biol; 2007 May; 8():14. PubMed ID: 17480240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effects of interaction between vascular endothelial cells and monocytes on expression of matrix metalloproteinase-2 and of tissue inhibitor of metalloproteinases 2 and regulation of pravastatin].
    Zheng W; Yang XH
    Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):105-8. PubMed ID: 15842807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts.
    Afzal S; Lalani EN; Poulsom R; Stubbs A; Rowlinson G; Sato H; Seiki M; Stamp GW
    Hum Pathol; 1998 Feb; 29(2):155-65. PubMed ID: 9490275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TIMP-2 is required for efficient activation of proMMP-2 in vivo.
    Wang Z; Juttermann R; Soloway PD
    J Biol Chem; 2000 Aug; 275(34):26411-5. PubMed ID: 10827175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional interplay between type I collagen and cell surface matrix metalloproteinase activity.
    Ellerbroek SM; Wu YI; Overall CM; Stack MS
    J Biol Chem; 2001 Jul; 276(27):24833-42. PubMed ID: 11331272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MT1-MMP in rat testicular development and the control of Sertoli cell proMMP-2 activation.
    Longin J; Guillaumot P; Chauvin MA; Morera AM; Le Magueresse-Battistoni B
    J Cell Sci; 2001 Jun; 114(Pt 11):2125-34. PubMed ID: 11493648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells.
    Yan L; Moses MA; Huang S; Ingber DE
    J Cell Sci; 2000 Nov; 113 ( Pt 22)():3979-87. PubMed ID: 11058085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences between scirrhous and non-scirrhous human gastric carcinomas from the aspect of proMMP-2 activation regulated by TIMP-3.
    Yokoyama T; Nakamura H; Otani Y; Kubota T; Fujimoto N; Seiki M; Kitajima M; Okada Y
    Clin Exp Metastasis; 2004; 21(3):223-33. PubMed ID: 15387372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Propionibacterium acnes stimulates pro-matrix metalloproteinase-2 expression through tumor necrosis factor-alpha in human dermal fibroblasts.
    Choi JY; Piao MS; Lee JB; Oh JS; Kim IG; Lee SC
    J Invest Dermatol; 2008 Apr; 128(4):846-54. PubMed ID: 18049448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The proMMP-2 activation rate in patients with chronic viral liver disease.
    Murawaki Y; Ikuta Y; Koda M; Okamoto K; Mimura K
    Clin Chim Acta; 2002 Oct; 324(1-2):99-103. PubMed ID: 12204430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell surface phenotype and increased penetration of human multidrug-resistant ovarian carcinoma cells into in vitro collagen-fibroblasts matrix.
    Sedlák J; Sedláková O; Hlavcák P; Hunáková L; Bízik J; Grófová M; Chorváth B
    Neoplasma; 1996; 43(6):389-95. PubMed ID: 8996563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-1alpha enhances type I collagen-induced activation of matrix metalloproteinase-2 in odontogenic keratocyst fibroblasts.
    Kubota Y; Oka S; Nakagawa S; Shirasuna K
    J Dent Res; 2002 Jan; 81(1):23-7. PubMed ID: 11820363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Galardin inhibits collagen degradation by rabbit keratocytes by inhibiting the activation of pro-matrix metalloproteinases.
    Hao JL; Nagano T; Nakamura M; Kumagai N; Mishima H; Nishida T
    Exp Eye Res; 1999 May; 68(5):565-72. PubMed ID: 10328970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cellular uptake of proMMP-2:TIMP-2 complexes by the endocytic receptor megalin/LRP-2.
    Johanns M; Lemoine P; Janssens V; Grieco G; Moestrup SK; Nielsen R; Christensen EI; Courtoy PJ; Emonard H; Marbaix E; Henriet P
    Sci Rep; 2017 Jun; 7(1):4328. PubMed ID: 28659595
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of monocyte MMP-9 production by TNF-alpha and a tumour-derived soluble factor (MMPSF).
    Leber TM; Balkwill FR
    Br J Cancer; 1998 Sep; 78(6):724-32. PubMed ID: 9743290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.